Table 6.
Chr | Cytoband | Gene | CN Event |
Expression | Clinical Features |
p-Value |
---|---|---|---|---|---|---|
3 | p21.2–p21.3 | BAP1 | Loss | Downregulation | Fuhrman Grade (1–2) | 0.02 |
5 | q34–q35.3 | FLT4 | Gain | Upregulation | Tumor size (>7 cm) | 0.007 |
5 | q34–q35.3 | NSD1 | Gain | Upregulation | Tumor size (>7 cm) | 0.007 |
Clinical Stage (3-4) | 0.01 | |||||
6 | q23.2–q23.3 | MYB | Loss | Downregulation | Fuhrman Grade (3-4) | 0.02 |
9 | p21.3 | MLLT3 | Loss | Downregulation | Metastasis | 0.005 |
Clinical Stage (3–4) | 0.02 | |||||
Tumor size (>7 cm) | 0.01 | |||||
Outcome (death) | 0.02 | |||||
Fuhrman Grade (3–4) | 0.01 |